Telotristat etiprate: Phase II data

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 23 patients with refractory carcinoid syndrome showed that 5 patients

Read the full 216 word article

How to gain access

Continue reading with a
two-week free trial.